A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

Background: Recent studies have reported findings regarding the addition of pegylated interferon aligned -alpha (Peg- IFNα) to nucleos (t) analog ideas. This study was designed to compare the efficacy of Peg- IFNα therapy and tenofovir disoproxil fumarate (TDF) in combination with each treatment separately.


Methods: In this open-label, randomized clinical trial, treatment-naive hepatitis B e antigen (HBeAg) -negative patients were randomly assigned to three treatment groups: Group A: Peg- IFNα (180 mcg / week) with TDF (300 mg / day); Group B: TDF (300 mg / day); and Group C: Peg- IFNα (180 mcg / week). intervention runs 48 weeks and patients were followed every 12 weeks. Primary endpoint was the burden of HBV DNA <20 IU / mL.


Results: Group A, B and C, each consisting of 22, 23 and 22 patients, respectively. The number of patients with HBV DNA suppression in group A was significantly higher than in group B and C (P = 0.034). No significant differences were observed in the trend of normalization of serum ALT levels between the three groups (P = 0.082). At week 48, the combination therapy was significantly more effective in suppressing HBV DNA concentrations below detection levels of TDF monotherapy (OR = 2.1, 95% CI: 1.18 to 4.15; P = 0.034). In addition, the comparison between the monotherapy arm revealed that both interventions have the same effect on the overall outcome (OR = 1.24, 95% CI: 1.02 to 5.8; P = 0.062).


Conclusion: A Peg- IFNα and TDF combination therapy resulted in a good and safe virologic response in patients with HBeAg negative. Monotherapy with Peg-IFNα or TDF benefit was limited compared.

 A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study
A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

Double-blind, randomized trial to compare the efficacy of escitalopram compared to citalopram for depression induced interferon in patients with hepatitis C

Objective: The objective of this study was to compare two antidepressant drug citalopram and escitalopram on the basis of success in depressed patients of hepatitis C patients who received interferon.


Methods: In a double-blind randomized trial, patients with hepatitis C visit the National institute liver and gastro intestinal diseases (NILGID), Dow University Hospital, screened for depression before starting treatment with interferon. Institutional review board approval was obtained and references no.is mail: IRB-682 / DUHS / approval / 2016/169. Patients with a history of depression were excluded from the study. The patients who started therapy with interferon assessed for depression at baseline and then at each visit. Those who develop depression were randomly assigned to receive either citalopram or escitalopram. treatment groups was assessed by a scale of depression every time they visit the clinic. Two antidepressants compared to their success in an interval of 4 weeks, 8weeks and then 12 weeks.

IFNA16 ORF Vector (Human) (pORF)

ORF021358 1.0 ug DNA Ask for price

IFNA4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV647509 1.0 ug DNA
EUR 616.8

IFNA4 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV647513 1.0 ug DNA
EUR 616.8

IFNA1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV683185 1.0 ug DNA
EUR 616.8

IFNA1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV683189 1.0 ug DNA
EUR 616.8

IFNA20P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV729275 1.0 ug DNA Ask for price

IFNA20P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV729279 1.0 ug DNA Ask for price

IFNA11P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV763643 1.0 ug DNA
EUR 1173.6

IFNA11P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV763647 1.0 ug DNA
EUR 1173.6

IFNA12P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV763649 1.0 ug DNA
EUR 1173.6

IFNA12P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV763653 1.0 ug DNA
EUR 1173.6

IFNA22P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV763655 1.0 ug DNA
EUR 1173.6

IFNA22P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV763659 1.0 ug DNA
EUR 1173.6

IFNA4 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV647514 1.0 ug DNA
EUR 616.8

IFNA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV706467 1.0 ug DNA
EUR 540

IFNA4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV706471 1.0 ug DNA
EUR 540

IFNA1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV706491 1.0 ug DNA
EUR 540

IFNA1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV706495 1.0 ug DNA
EUR 540

IFNA1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV683190 1.0 ug DNA
EUR 616.8

IFNA20P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729280 1.0 ug DNA Ask for price

IFNA11P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV763648 1.0 ug DNA
EUR 1173.6

IFNA12P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV763654 1.0 ug DNA
EUR 1173.6

IFNA22P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV763660 1.0 ug DNA
EUR 1173.6

IFNA4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV706472 1.0 ug DNA
EUR 540

IFNA1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV706496 1.0 ug DNA
EUR 540

IFNA13 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV791922 1.0 ug DNA
EUR 448.8

IFNA4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV647510 1.0 ug DNA
EUR 616.8

IFNA1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV683186 1.0 ug DNA
EUR 616.8

IFNA20P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV729276 1.0 ug DNA Ask for price

IFNA11P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV763644 1.0 ug DNA
EUR 1173.6

IFNA12P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV763650 1.0 ug DNA
EUR 1173.6

IFNA22P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV763656 1.0 ug DNA
EUR 1173.6

IFNA20P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV729277 1.0 ug DNA Ask for price

IFNA20P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV729278 1.0 ug DNA Ask for price

IFNA11P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV763645 1.0 ug DNA
EUR 1243.2

IFNA11P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV763646 1.0 ug DNA
EUR 1243.2

IFNA12P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV763651 1.0 ug DNA
EUR 1243.2

IFNA12P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV763652 1.0 ug DNA
EUR 1243.2

IFNA22P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV763657 1.0 ug DNA
EUR 1243.2

IFNA22P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV763658 1.0 ug DNA
EUR 1243.2

IFNA4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV647511 1.0 ug DNA
EUR 686.4

IFNA4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV647512 1.0 ug DNA
EUR 686.4

IFNA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV706468 1.0 ug DNA
EUR 540

IFNA1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV706492 1.0 ug DNA
EUR 540

IFNA1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV683187 1.0 ug DNA
EUR 686.4

IFNA1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV683188 1.0 ug DNA
EUR 686.4

IFNA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV706469 1.0 ug DNA
EUR 609.6

IFNA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV706470 1.0 ug DNA
EUR 609.6

IFNA1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV706493 1.0 ug DNA
EUR 609.6

IFNA1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV706494 1.0 ug DNA
EUR 609.6

IFNA16 Protein Vector (Human) (pPM-C-HA)

PV085431 500 ng Ask for price

IFNA17 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL303989 5 µg/vial Ask for price

Ifna11 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL501045 5 µg/vial Ask for price

IFNA21 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL315496 5 µg/vial Ask for price

Ifna13 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL506870 5 µg/vial Ask for price

Ifna12 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL507368 5 µg/vial Ask for price

Ifna15 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL514892 5 µg/vial Ask for price

Ifna14 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL512221 5 µg/vial Ask for price

IFNA14 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL312238 5 µg/vial Ask for price

IFNA13 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL312239 5 µg/vial Ask for price

IFNA10 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL312240 5 µg/vial Ask for price

IFNA16 Protein Vector (Human) (pPB-C-His)

PV085429 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPB-N-His)

PV085430 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPM-C-His)

PV085432 500 ng Ask for price

IFNA7 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL303986 5 µg/vial Ask for price

IFNA6 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL303987 5 µg/vial Ask for price

IFNA4 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL303988 5 µg/vial Ask for price

IFNA1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL303990 5 µg/vial Ask for price

Ifna1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL501044 5 µg/vial Ask for price

Ifna2 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL501046 5 µg/vial Ask for price

Ifna5 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL501047 5 µg/vial Ask for price

Ifna7 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL501049 5 µg/vial Ask for price

Ifna9 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL512618 5 µg/vial Ask for price

Ifna6 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL508669 5 µg/vial Ask for price

Ifna4 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL509418 5 µg/vial Ask for price

IFNA8 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL312234 5 µg/vial Ask for price

IFNA5 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL312235 5 µg/vial Ask for price

IFNA2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL312236 5 µg/vial Ask for price

IFNA16 siRNA

20-abx920220
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

IFNA16 (untagged)-Human interferon, alpha 16 (IFNA16)

SC303136 10 µg Ask for price

IFNAR1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV640375 1.0 ug DNA
EUR 818.4

IFNAR1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV640379 1.0 ug DNA
EUR 818.4

IFNA16 Antibody

37641-100ul 100ul
EUR 302.4

IFNA16 Antibody

1-CSB-PA689914
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000

IFNA16 Antibody

1-CSB-PA011036LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

IFNA16 Antibody

E037641 100μg/100μl
EUR 255
Description: Available in various conjugation types.

IFNA16 Antibody

37641 100ul
EUR 319

IFNAR1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV640380 1.0 ug DNA
EUR 818.4

IFNA16 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL312237V 500 ul each Ask for price

IFNA16 (GFP-tagged) - Human interferon, alpha 16 (IFNA16)

RG214713 10 µg Ask for price

IFNA16 sgRNA CRISPR Lentivector set (Human)

K1020001 3 x 1.0 ug
EUR 406.8

IFNA16 (Myc-DDK-tagged)-Human interferon, alpha 16 (IFNA16)

RC214713 10 µg Ask for price

IFNA16 Rabbit pAb

E2161774 100ul
EUR 225
Description: Available in various conjugation types.

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 1)

K1020002 1.0 ug DNA
EUR 184.8

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 2)

K1020003 1.0 ug DNA
EUR 184.8

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 3)

K1020004 1.0 ug DNA
EUR 184.8

IFNA16 Conjugated Antibody

C37641 100ul
EUR 476.4

IFNAR1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV640376 1.0 ug DNA
EUR 818.4

Lenti ORF particles, IFNA16 (mGFP-tagged) - Human interferon, alpha 16 (IFNA16), 200ul, >10^7 TU/mL

RC214713L2V 200 µl Ask for price

Lenti ORF particles, IFNA16 (mGFP-tagged) - Human interferon, alpha 16 (IFNA16), 200ul, >10^7 TU/mL

RC214713L4V 200 µl Ask for price

IFNA16 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector

TR312237 5 µg/vial Ask for price

IFNAR1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV640377 1.0 ug DNA
EUR 888

IFNAR1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV640378 1.0 ug DNA
EUR 888

Lenti ORF particles, IFNA16 (Myc-DDK tagged) - Human interferon, alpha 16 (IFNA16), 200ul, >10^7 TU/mL

RC214713L1V 200 µl Ask for price

Lenti ORF particles, IFNA16 (Myc-DDK tagged) - Human interferon, alpha 16 (IFNA16), 200ul, >10^7 TU/mL

RC214713L3V 200 µl Ask for price

Ifnar1 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL704488 5 µg/vial Ask for price

Ifnab - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL501050 5 µg/vial Ask for price

Human IFNA16 shRNA Plasmid

20-abx952338
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

IFNAR2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL303985 5 µg/vial Ask for price

Ifnar2 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL511856 5 µg/vial Ask for price

Ifnar1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL509551 5 µg/vial Ask for price

IFNAR1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL312233 5 µg/vial Ask for price

IFNA16 Antibody, HRP conjugated

1-CSB-PA011036LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

IFNA16 Antibody, FITC conjugated

1-CSB-PA011036LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

IFNA16 Antibody, Biotin conjugated

1-CSB-PA011036LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Human IFNA16 knockout cell line

ABC-KH7185 1 vial Ask for price
Description: Human IFNA16 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K1020005 3 x 1.0 ug
EUR 451.2

Human IFNA16 Protein Lysate 20ug

IHUIFNA16PLLY20UG each
EUR 213
Description: Human IFNA16 Protein Lysate 20ug

Human IFNA16 knockdown cell line

ABC-KD7185 1 vial Ask for price
Description: Human IFNA16 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Interferon Alpha 16 (IFNA16) Antibody

20-abx211357
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Ifna16 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vectorr

TR506871 5 µg/vial Ask for price

Recombinant Interferon Alpha 16 (IFNa16)

4-RPG968Mu01
  • EUR 636.10
  • EUR 294.00
  • EUR 2055.36
  • EUR 765.12
  • EUR 1410.24
  • EUR 501.60
  • EUR 4958.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Interferon Alpha 16 expressed in: E.coli

OCOA14251-20UG - IFNA16 Protein Lysate

OCOA14251-20UG 20ug
EUR 169

Recombinant Interferon Alpha 16 (IFNa16)

RPU56000-100ug 100ug
EUR 760.1

Recombinant Interferon Alpha 16 (IFNa16)

RPU56000-1mg 1mg
EUR 2995.2

Recombinant Interferon Alpha 16 (IFNa16)

RPU56000-50ug 50ug
EUR 460.8

Recombinant Interferon Alpha 16 (IFNa16)

RPG968Mu01 10ug
EUR 192

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K1020006 1.0 ug DNA
EUR 200.4

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K1020007 1.0 ug DNA
EUR 200.4

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K1020008 1.0 ug DNA
EUR 200.4

IFNA16 3'UTR GFP Stable Cell Line

TU060478 1.0 ml
EUR 1672.8

Recombinant Human Interferon alpha-16 (IFNA16)

RPC28661-100ug 100ug
EUR 635.8

Recombinant Human Interferon alpha-16 (IFNA16)

RPC28661-1mg 1mg
EUR 2885.2

Recombinant Human Interferon alpha-16 (IFNA16)

RPC28661-20ug 20ug
EUR 353.4

Recombinant Human Interferon alpha-16 (IFNA16)

CSB-EP011036HU 7794 mg Ask for price

Recombinant Human Interferon alpha-16 (IFNA16)

CSB-YP011036HU 10567 mg Ask for price

Lenti ORF clone of Human interferon, alpha 16 (IFNA16), mGFP tagged

RC214713L2 10 µg Ask for price

Lenti ORF clone of Human interferon, alpha 16 (IFNA16), mGFP tagged

RC214713L4 10 µg Ask for price

IFNA16 3'UTR Luciferase Stable Cell Line

TU010478 1.0 ml
EUR 1672.8

Human Interferon alpha- 16, IFNA16 ELISA KIT

ELI-48218h 96 Tests
EUR 988.8

Human Interferon Alpha 16(IFNa16)ELISA Kit

QY-E03458 96T
EUR 433.2

Human Interferon Alpha 16 (IFNa16) Protein (Active)

20-abx655681
  • EUR 1345.20
  • EUR 493.20
  • EUR 4468.80
  • EUR 1629.60
  • EUR 910.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

AAP60735-100UG - IFNA16 Peptide - C-terminal region

AAP60735-100UG 100ug
EUR 99

ARP60735_P050-25UL - IFNA16 Antibody - C-terminal region

ARP60735_P050-25UL 25ul
EUR 99

Lenti ORF clone of Human interferon, alpha 16 (IFNA16), Myc-DDK-tagged

RC214713L1 10 µg Ask for price

Lenti ORF clone of Human interferon, alpha 16 (IFNA16), Myc-DDK-tagged

RC214713L3 10 µg Ask for price

ARP60735_P050 - IFNA16 Antibody - C-terminal region (ARP60735_P050)

ARP60735_P050 100ul
EUR 389

h IFNAR2 inducible lentiviral particles

LVP774 1x107 IFU/ml x 200ul
EUR 541.2
Description: Pre-made over-expression lentivirus for expressing human target: IFNAR2 (interferon (alpha, beta and omega) receptor 2), [alternative names: IFN-alpha-REC; IFN-R; IFNABR; IFNARB]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_207585.2. It also contains a RFP-Blasticidin dual selection marker.

IFNA17 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL303989V 500 ul each Ask for price

Ifna11 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL501045V 500 ul each Ask for price

IFNA21 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL315496V 500 ul each Ask for price

Ifna13 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL506870V 500 ul each Ask for price

Ifna12 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL507368V 500 ul each Ask for price

Ifna14 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL512221V 500 ul each Ask for price

IFNA14 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL312238V 500 ul each Ask for price

IFNA13 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL312239V 500 ul each Ask for price

IFNA10 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL312240V 500 ul each Ask for price

IFNA16 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each

SR302331 2 nmol Ask for price

Ifna16 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each

SR404704 2 nmol Ask for price

IFNA7 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL303986V 500 ul each Ask for price

IFNA6 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL303987V 500 ul each Ask for price

IFNA4 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL303988V 500 ul each Ask for price

IFNA1 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL303990V 500 ul each Ask for price

Ifna1 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL501044V 500 ul each Ask for price

Ifna2 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL501046V 500 ul each Ask for price

Ifna5 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL501047V 500 ul each Ask for price

Ifna7 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL501049V 500 ul each Ask for price

Ifna9 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL512618V 500 ul each Ask for price

Ifna6 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL508669V 500 ul each Ask for price

Ifna4 - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL509418V 500 ul each Ask for price

IFNA8 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL312234V 500 ul each Ask for price

IFNA5 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL312235V 500 ul each Ask for price

IFNA2 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL312236V 500 ul each Ask for price

IFNA13 ORF Vector (Human) (pORF)

ORF005213 1.0 ug DNA
EUR 114

IFNA21 ORF Vector (Human) (pORF)

ORF005214 1.0 ug DNA
EUR 114

IFNA10 ORF Vector (Human) (pORF)

ORF013324 1.0 ug DNA
EUR 424.8

IFNA14 ORF Vector (Human) (pORF)

ORF021357 1.0 ug DNA
EUR 486

IFNA17 ORF Vector (Human) (pORF)

ORF021359 1.0 ug DNA
EUR 486

Ifna11 ORF Vector (Mouse) (pORF)

ORF047683 1.0 ug DNA
EUR 607.2

Ifna12 ORF Vector (Mouse) (pORF)

ORF047684 1.0 ug DNA
EUR 607.2

Ifna13 ORF Vector (Mouse) (pORF)

ORF047685 1.0 ug DNA
EUR 607.2

Ifna14 ORF Vector (Mouse) (pORF)

ORF047686 1.0 ug DNA
EUR 607.2

IFNA11P ORF Vector (Human) (pORF)

ORF021355 1.0 ug DNA Ask for price

IFNA12P ORF Vector (Human) (pORF)

ORF021356 1.0 ug DNA Ask for price

IFNA20P ORF Vector (Human) (pORF)

ORF021361 1.0 ug DNA Ask for price

IFNA22P ORF Vector (Human) (pORF)

ORF021362 1.0 ug DNA Ask for price

Ifna1 ORF Vector (Rat) (pORF)

ORF068513 1.0 ug DNA
EUR 607.2

Ifna4 ORF Vector (Rat) (pORF)

ORF068514 1.0 ug DNA
EUR 607.2

IFNA13 Protein Vector (Human) (pPM-C-HA)

PV020851 500 ng
EUR 394.8

IFNA21 Protein Vector (Human) (pPM-C-HA)

PV020855 500 ng
EUR 394.8


Results: In the present study 80 patients were randomized to receive either citalopram or escitalopram. The research result was better in patients treated with escitalopram. Significant changes in depression scores from the beginning to the end of the study was greater in the escitalopram group is 10.41 compared with citalopram group is 14.17. Differences in depression scores were also calculated as 4.28 and.3.76 (p <0.001) for both drugs at week 8 and week 12 respectively, which were statistically significant. Difference in depression scores were also calculated for the sex of 0.576 (p = 0.497) and age of 0.950 (p = 0.265), were found to be significant, statistically.


Conclusion: The results show the superiority of escitalopram over citalopram, the drug is twice as potent as racemic mixtures. In addition the drug is well tolerated and showed a better effect. Escitalopram proven to be a safer alternative to citalopram.